Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

Share Price is delayed by 15 minutes
Get Live Data
81.00    -1.50 (-1.82%)
Bid:
80.00
Ask:
82.00
Spread: 2.00 (2.50%)
Market Cap: £11.75m
RBD Live PriceLast checked at - London Stock Exchange

Intraday Reabold Resources Share Chart

Contract Gain

11 Apr 2006 07:30

Adventis Group PLC11 April 2006 For release Adventis Group plc ("Adventis") Contract Gain Adventis ("ATG/L"), the multimedia marketing and advertising agency, announcesthat Affiniti UK Ltd, its Bucks-based healthcare agency has been appointed bySanofi Pasteur MSD, an existing client, to work on a campaign for a new vaccinethat could protect the elderly against shingles. An attack of shingles can be extremely painful, with around a quarter ofsufferers going on to develop post herpetic neuralgia, an often debilitatingillness which can last for months or even years. In the UK, about 250,000 peoplesuffer from shingles each year, almost half of these being over 60 years old. Affiniti won this 3-way pitch with a strong strategic approach, which furtherextends their vaccine product portfolio. Commenting, Affiniti MD, Stuart Tennant, said: "Everyone in the agency isdelighted. We continue to build market share in the healthcare sector," whereas,Charles Phillpot, Adventis CEO said in his statement for the year ended 31December 2005: "Revenue by sector grew over that achieved in the previous year." - ENDS - Editor's NotesAdventis Group plc is an AIM listed, full service marketing and advertisingagency, providing services to the property, healthcare and financial servicesindustries.Through its six operating companies the company provides a complete range ofcommunication services, including corporate identity programmes, advertisingcampaigns, media planning & buying, literature, public relation, packaging,exhibitions, research and planning, interiors, signage and digital media.Adventis employs over 80 staff in London and the South East.www.adventis.co.uk In January 2005, Adventis acquired Affiniti (UK) Ltd, a specialised UKhealthcare advertising agency with clients such as Allergan, Sanofi Pasteur MSD,Chiron Vaccines, Eden Biopharm, Leo Pharma and Serono. The acquisition hasperformed very well in 2005 with a pre-tax profit of £247,000 and builds on thefoothold Adventis Group already had in this profitable market. Enquiries: Adventis Group plcCharles Phillpot, Chief Executive Officer 020 7034 4750 Affiniti (UK) LtdStuart Tennant, Managing Director 01494 775 213 Seymour PierceJohn Depasquale 020 7107 8000 Binns & Co PR Ltd 020 7786 9600Peter Binns 07768 392 582Annie Evangeli 07778 507 162 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th May 20227:00 amRNSCompletion of Equity Exchange Agreement
24th May 20227:00 amRNSReabold North Sea – Presentation on New Licences
23rd May 20227:00 amRNSShareholder Approval Received for Equity Exchange
13th May 20227:00 amRNSAppointment of Chief Financial Officer
4th May 20227:00 amRNSOffer for Corallian and acquisition of licences
3rd May 20227:00 amRNSUpdate on Equity Exchange with Daybreak Oil & Gas
17th Mar 202212:21 pmRNSPlanning Application Approval for Next Phase
25th Feb 20227:00 amRNSInvestor Presentation
25th Feb 20227:00 amRNSUpdate on Equity Exchange with Daybreak Oil & Gas
24th Feb 20224:42 pmRNSSecond Price Monitoring Extn
24th Feb 20224:37 pmRNSPrice Monitoring Extension
17th Feb 202212:38 pmRNSAmendment of Existing Option Terms
25th Jan 20229:05 amRNSSecond Price Monitoring Extn
25th Jan 20229:00 amRNSPrice Monitoring Extension
17th Jan 20224:41 pmRNSSecond Price Monitoring Extn
17th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Jan 20227:00 amRNSWest Newton Flow Rate Update
23rd Dec 20217:00 amRNSVictory – Submission of Draft FDP
2nd Dec 20212:00 pmRNSPrice Monitoring Extension
26th Nov 20217:00 amRNSWest Newton – Rathlin’s Update to Residents
22nd Oct 20217:00 amRNSDirectors’ Dealings
21st Oct 20217:00 amRNSCreation of Enhanced California E&P Company
20th Oct 202111:05 amRNSSecond Price Monitoring Extn
20th Oct 202111:00 amRNSPrice Monitoring Extension
20th Oct 20217:00 amRNSVictory CPR and Corallian Strategic Review
13th Oct 20217:00 amRNSWest Newton Well Test Operations Update
4th Oct 202111:00 amRNSPrice Monitoring Extension
1st Oct 20217:00 amRNSWest Newton A Site Planning Decision
30th Sep 20214:05 pmRNSUnaudited Interim Results 6months ended 30 June 21
31st Aug 20217:00 amRNSWest Newton Operations Update
28th Jul 20213:52 pmRNSResults of AGM
21st Jul 20217:00 amRNSWest Newton Operations Update
25th Jun 20217:00 amRNSEnvironmental Baseline Survey Completed at Victory
23rd Jun 20217:00 amRNSNotice of Annual General Meeting
21st Jun 20217:00 amRNSExtension of Parta Exploration Licence in Romania
10th Jun 20217:00 amRNSFull Year Results for the year ended 31 Dec 2020
25th May 20217:00 amRNSWest Newton Operations Update
19th May 20217:00 amRNSTR-1
14th May 20218:15 amRNSTotal Voting Rights
10th May 20217:00 amRNSCompletion of Offer to Acquire Shares of Corallian
10th May 20217:00 amRNSWest Newton CPR
27th Apr 20217:00 amRNSConditional Offer to Acquire Shares in Corallian
20th Apr 20217:00 amRNSWest Newton Operations Update
30th Mar 20217:00 amRNSWest Newton Test Programme Update
22nd Mar 20217:00 amRNSWest Newton Online Consultation Launched
3rd Mar 20217:00 amRNSPartial Sale of Convertible Loan Notes
26th Feb 20213:00 pmRNSAmendment of Existing Option Terms
24th Feb 20213:01 pmRNSConfirmation of increased investment in Corallian
23rd Feb 20214:30 pmRNSHolding(s) in Company
22nd Feb 20217:00 amRNSIncreased investment in Corallian

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.